Accelerated approval
The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases
13
Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints
17
The Value of Innovation in Oncology: Recognizing Emerging Benefits Over Time
20
Precision medicine becomes reality—tumor type-agnostic therapy
7
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
7
Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
7
Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
9
USEFUL APPROVAL PROCESSES
6
Repair Design Approval
10
Leveraging Open Hardware to alleviate the burden of COVID-19 on global health systems
12
APPROVAL AND VESTING ORDER
5
APPROVAL OF SATIVEX WITH CONDITIONS
5
Secondary Invoice Approval
17
MDMA Approval Checklist
6
Final Record of Approval
26
APPROVAL AMENDMENT HISTORY
11
Accelerated ADMM based on Accelerated Douglas-Rachford Splitting
6
Presidential Approval in Perspective
12
Twin-circumstance Data access management with capable revocation for Multi-authority cloud storage system
7
GPU based parallel acceleration for fast C-arm cone-beam CT reconstruction
14